Zacks.com on MSN9d
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer
GSK plc GSK announced that the European Commission has granted approval for the expanded use of Jemperli (dostarlimab) plus ...
PMLiVE10d
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use
GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...
Hosted on MSN2d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK announces expanded EU approval in endometrial cancer for Jemperli combo
GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...
GSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick Facts
GSK plc (GSK, GSK.L) announced the European Commission has approved Jemperli in combination with chemotherapy for first-line ...
EU regulators expand usage of GSK's Jemperli cancer drug
European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced ...
Nasdaq10d
GSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick Facts
(RTTNews) - GSK plc (GSK, GSK.L) announced the European Commission has approved Jemperli in combination with chemotherapy for first-line treatment of adult patients with primary advanced or ...
Daily9d
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer
London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...